AGMT
Showing 1 - 25 of 35
Infectious Disease, COVID-19 Trial in Austria
Unknown status
- Infectious Disease
- COVID-19
-
Feldkirch, Austria
- +3 more
Nov 26, 2020
Breast Cancer, Breast Carcinoma, Breast Tumor Trial in Austria
Recruiting
- Breast Cancer
- +2 more
-
Linz, Oberösterreich, Austria
- +14 more
Feb 21, 2022
Lymphoma, Large B-Cell, Diffuse Trial in Austria (Venetoclax, Obinutuzumab)
Completed
- Lymphoma, Large B-Cell, Diffuse
-
Graz, Austria
- +5 more
Feb 15, 2022
Multiple Myeloma Trial in Austria, Germany, Israel (Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA], Placebo 1.7 ml
Active, not recruiting
- Multiple Myeloma
- Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]
- Placebo 1.7 ml Subcutaneous Solution
-
Graz, Austria
- +9 more
Aug 24, 2022
Newly Diagnosed Multiple Myeloma Trial in Austria (Isatuximab-Irfc 20 MG/ML [Sarclisa], Lenalidomide, Dexamethasone Oral)
Recruiting
- Newly Diagnosed Multiple Myeloma
- Isatuximab-Irfc 20 MG/ML [Sarclisa]
- +2 more
-
Innsbruck, Tirol, Austria
- +15 more
Aug 24, 2022
ALK+ Anaplastic Large Cell Lymphoma Trial in Wien (Brentuximab vedotin, Imatinib)
Terminated
- ALK+ Anaplastic Large Cell Lymphoma
- Brentuximab vedotin
- Imatinib
-
Wien, AustriaUniversitätsklinik f. Innere Medizin I, AKH Wien, Klinische Abte
Feb 15, 2022
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Austria (Bendamustine, Alemtuzumab)
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
-
Innsbruck, Tirol, Austria
- +6 more
Feb 15, 2022
Cancer of Unknown Origin, Cancer Refractory, Cancer of Stomach Trial in Austria (Genomic testing)
Recruiting
- Cancer of Unknown Origin
- +14 more
- Genomic testing
-
Feldkirch, Austria
- +10 more
Feb 18, 2022
Pancreatic Cancer Non-resectable, Chemo-induced Nausea and Vomiting, Pancreatic Cancer Metastatic Trial in Austria, Germany
Recruiting
- Pancreatic Cancer Non-resectable
- +2 more
- Dronabinol in Oral Dosage Form
- Placebo in Oral Dosage Form
-
Wels, Oberösterreich, Austria
- +10 more
Jan 18, 2022
Registry on Hypomethylating Agents in Myeloid Neoplasms
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- +2 more
- non interventional
-
Feldkirch, Austria
- +19 more
Jul 20, 2021
Metastatic Colorectal Cancer Trial in Austria (FOLFIRI + Cetuximab, modifiedFOLFOX6 + Cetuximab)
Completed
- Metastatic Colorectal Cancer
- FOLFIRI + Cetuximab
- modifiedFOLFOX6 + Cetuximab
-
Linz, Oberösterreich, Austria
- +10 more
Dec 18, 2020
Gastric Cancer, Unresectable Trial in Austria (Oxaliplatin, Irinotecan, Bevacizumab, Docetaxel)
Completed
- Gastric Cancer
- Unresectable
- Oxaliplatin, Irinotecan, Bevacizumab, Docetaxel
-
Innsbruck, Austria
- +6 more
Nov 26, 2020
Lung Cancer, NSCLC Stage IV, NSCLC, Stage III Trial in Linz, Innsbruck, Salzburg
Recruiting
- Lung Cancer
- +4 more
-
Linz, Oberösterreich, Austria
- +2 more
Dec 3, 2020
Myeloid Diseases Trial in Austria (Non-interventional)
Recruiting
- Myeloid Diseases
- Non-interventional
-
Feldkirch, Austria
- +14 more
Dec 3, 2020
Triple-Negative Breast Cancer Trial in Austria (Ixazomib, Carboplatin)
Terminated
- Triple-Negative Breast Cancer
-
Wels, Oberösterreich, Austria
- +11 more
Nov 26, 2020
Gastric Cancer Trial in Wenzhou (Blood collection)
Recruiting
- Gastric Cancer
- Blood collection
-
Wenzhou, Zhejiang, ChinaNo. 109, Xueyuan West Road, Lucheng District, Wenzhou City，Zheji
Aug 11, 2021
Squamous Cell Carcinoma of the Hypopharynx Stage III, Squamous Cell Carcinoma of the Hypopharynx Stage IV, Laryngeal Squamous
Terminated
- Squamous Cell Carcinoma of the Hypopharynx Stage III
- +8 more
- Standard care of parenteral nutrition
- +4 more
-
Feldkirch, Austria
- +6 more
Apr 30, 2020
Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer Trial in Worldwide (biological, drug, procedure)
Completed
- Adenocarcinoma of the Gastroesophageal Junction
- Esophageal Cancer
- cetuximab
- +4 more
-
Feldkirch, Austria
- +56 more
Oct 19, 2020
Chronic Phase Chronic Myeloid Leukemia Trial in Austria (P1101)
Completed
- Chronic Phase Chronic Myeloid Leukemia
-
Wels, Oberösterreich, Austria
- +3 more
Jan 3, 2019
Follicular T-NHL Lymphoma, Rituximab Maintenance Trial (Rituximab)
Completed
- Follicular T-NHL Lymphoma
- Rituximab Maintenance
- (no location specified)
Jan 8, 2018
Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Trial in Austria (Rituximab and Lenalidomide)
Completed
- Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)
- Rituximab and Lenalidomide
-
Linz, Oberösterreich, Austria
- +4 more
Jun 19, 2017